Azusa Nagao Masato Bingo Tomoko Yamaguchi Katsuyuki Fukutake
10.7759/cureus.33573
Cureus
2023 Jan 9;15(1):e33573.
albutrepenonacog alfa factor xi hemophilia b personalized usage prophylaxis real-world clinical practice
CC BY
https://pubmed.ncbi.nlm.nih.gov/36779089/
Case Reports
PMC9909124
36779089
Real-World Use of Albutrepenonacog Alfa, A Recombinant Coagulation Factor IX Albumin Fusion Protein, for Personalized Prophylaxis in Japanese Individuals With Hemophilia B: A Case Series
2023